FDA strengthens device monitoring

Following a 12-month examination of the way medical devices are monitored for safety after approval, the USA's Food and Drug Administration (FDA) has launched a new programme to `transform and strengthen´ current monitoring of new technology as well as existing products.

The FDA Center for Devices and Radiological Health’s (CDRH) Postmarket Transformation Initiative aims to identify, analyse and act on problems more quickly, and alert the public sooner about potential medical device issues.

The Initiative will focus on: Developing an electronic reporting system for adverse medical device events; ways to identify medical devices including standardized and globally accepted names; ways to improve device information in patient records; improved internal collaboration on post market safety issues; and identifying opportunities to improve medical device safety via collaborative efforts with professional organizations and the medical device industry.

Initially, the CDRH’s Medical Device Postmarket Safety Program report, and accompanying recommendations for possible ways to address areas that need improvement, will be reviewed.

01.03.2006

Related articles

Photo

News • Respiratory and CVD monitoring devices

Commercial partnership to co-promote patient monitoring technologies

Nonin Medical, a provider of SpO₂ monitoring solutions, and CO₂ monitoring specialist Corscience have entered into a partnership to co-promote each other’s OEM product offerings.

Photo

News • Biocompatible electronic component

A 'smart' suture to monitor recovery progress

Korean researchers have developed a new type of 'smart' surgical suture that monitors the recovery process of a wound. This could improve orthopedic or general medical rehabilitation, the team hopes.

Photo

Opinion article • Wearable medical devices

Sweat analysis reveals a wealth of health information

Diagnosis and monitoring medical conditions, including cancer, diabetes, heart disease, and infections: In this opinion article, Alix Joseph (Linxens) explores the potential of sweat analysis.

Related products

Subscribe to Newsletter